ArticleCurrent medical mycology2016
Epidemiology and antifungal susceptibility of
Article in Current medical mycology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed.
- Article
- Detection of Candida Species in Genitourinary Tract among Immunocompromised Patients Attending Rural Teaching Hospital.Annals of African medicine · 2026Article
- Article
- Migration and standing variation in vaginal and rectal yeast populations in recurrent vulvovaginal candidiasis.mSystems · 2025Article
- Direct Identification of Yeasts from Blood Cultures and Body Fluids Using MALDI-TOF MS with Concurrent Antifungal Susceptibility Testing.Mycopathologia · 2025Article
- Article
- Article
- Isolation and identification of Candida species from catheter-associated urinary tract infection in Thamar city hospitals, Yemen.International microbiology : the official journal of the Spanish Society for Microbiology · 2025Article
- Article
- Time-to-Positivity for Candida in Bloodstream Infections: Prognostic Implications for Mortality.Cureus · 2024Article
- EpiCandIn: An open online resource for epidemiology of Candida infections in India.The Indian journal of medical research · 2024Article
- IncreasingCurrent medical mycology · 2024Article
- Evaluation of antifungal effect of amphotericin B in comparison with nystatin on Candida species derived from patients undergoing head-and-neck radiotherapy.Dental research journal · 2024Article
- Evaluation and comparison of antifungal effect of voriconazole with nystatin onDental research journal · 2023Article
- Coumarin-based combined computational study to design novel drugs against Candida albicans.Journal of microbiology (Seoul, Korea) · 2022Article
- Changes in urban soil yeast communities after a reduction in household waste during the COVID-19 pandemic.Pedobiologia · 2022Article
- Differential Response ofAntimicrobial agents and chemotherapy · 2022Article
- Article
- Candidemia: Changing dynamics from a tertiary care hospital in North India.Current medical mycology · 2022Article
- A complete clinico-epidemiological and microbiological profile of candidemia cases in a tertiary-care hospital in Western India.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background and purposeThe incidence of fungal infection as well as candidemia has increased significantly, contributing to morbidity and mortality in the developed countries. The alarming increase in infections with multidrug resistant bacteria is due to overuse of a broad spectrum antimicrobials, which leads to over growth of MATERIALS AND
methods
resultsOut of 70 samples,
conclusionSpecies-level identification of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.